| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 11/03/2011 | CA2797865A1 Methods, compositions, and kits for the treatment of matrix mineralization disorders |
| 11/03/2011 | CA2795613A1 Clay compositions |
| 11/03/2011 | CA2795275A1 Lyophilized formulation of pectin-adriamycin conjugate and preparation method thereof |
| 11/03/2011 | CA2792965A1 Stable aqueous mia/cd-rap formulations |
| 11/02/2011 | EP2383013A1 Microneedle device |
| 11/02/2011 | EP2382996A2 Lipid Film Structure Containing a Polyoxyalkylene Chain-Containing Lipid Derivative. |
| 11/02/2011 | EP2382995A2 Ligand conjugates of Vinca alkaloids, analogs and derivatives |
| 11/02/2011 | EP2382994A1 Ligand targeted nanocapsules for the delivery of RNAi and other agents |
| 11/02/2011 | EP2382993A1 Combination of drugs with protein-binding prodrugs |
| 11/02/2011 | EP2382990A1 Methods for treating cancer using an immunotoxin |
| 11/02/2011 | EP2382987A1 Storage of influenza vaccines without refrigeration |
| 11/02/2011 | EP2382971A1 Orally disintegrating tablet having inner core |
| 11/02/2011 | EP2382966A1 Micelle compositions and process for the preparation thereof |
| 11/02/2011 | EP2381968A1 Biopolymeric membrane for wound protection and repair |
| 11/02/2011 | EP2381964A1 Synthesis of polymer conjugates of indolocarbazole compounds |
| 11/02/2011 | EP2381963A2 A medical device loaded with formulations for targeted delivery of biologically active material/s and method of manufacture thereof |
| 11/02/2011 | EP2381962A1 Composition for prolonged release of heparin and use of the alginate-hydroxypropylcellulose gel for prolonged release of heparin |
| 11/02/2011 | EP2381961A1 Implantable devices for treating hiv |
| 11/02/2011 | EP2381960A1 Stable pharmaceutical composition containing at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents |
| 11/02/2011 | EP2381959A1 Stable vaccine compositions and methods of use |
| 11/02/2011 | EP2381930A2 Active coating of pharmaceutical dosage forms |
| 11/02/2011 | EP2381929A2 Pharmaceutical composition of lyophilized formulation and preparation method of the same |
| 11/02/2011 | EP2381916A2 Hydrogel composition for the treatment of dermatological disorders |
| 11/02/2011 | EP2068822B1 Self preserved aqueous pharmaceutical compositions |
| 11/02/2011 | EP1742665B1 Delivery system for bioactive agents on the basis of a polymeric drug carrier comprising an amphiphilic block polymer and a polylacticacid derivative |
| 11/02/2011 | EP1730194B1 Bi-specific antibodies for targeting cells involved in allergic-type reactions, compositions and uses thereof |
| 11/02/2011 | EP1417960B1 Sustained release micropellets and process for producing the same |
| 11/02/2011 | EP1339412B1 Formulation containing phosphate derivatives of electron transfer agents |
| 11/02/2011 | EP1299522B1 Alteration of cell membrane |
| 11/02/2011 | CN1871018B Pharmaceutical formulation comprising lanthanum compounds |
| 11/02/2011 | CN102232083A 禽流感疫苗 Bird flu vaccine |
| 11/02/2011 | CN102231991A Active particles for bio-analytical applications and methods for their preparation |
| 11/02/2011 | CN102231990A Pharmaceutical composition of n- [2, 4-bis (1, 1-dimethylethyl)-5- hydroxyphenyl]- 1, 4 -dihydro-4-oxoquinoline-3- carboxamide and administration thereof |
| 11/02/2011 | CN102231989A Ophthalmic device having therapeutic agent delivery capability and method of forming same |
| 11/02/2011 | CN102231981A Composition for sustained release delivery of proteins or peptides |
| 11/02/2011 | CN102231977A Delivery of dry formulations of octreotide |
| 11/02/2011 | CN102231976A Octreotide implant having a release agent |
| 11/02/2011 | CN102229924A Polyethylene glycol-modified Serratia protein-digesting enzyme as well as preparation method and application thereof |
| 11/02/2011 | CN102229667A Polyethylene glycol modified porcine alpha-interferon, preparation method and application thereof |
| 11/02/2011 | CN102228697A Application of microRNA (Ribonucleic Acid)-26 in preparing medicament for preventing and treating atrial fibrillation |
| 11/02/2011 | CN102228696A Polyethylene glycol-polyvinyl alcohol copolymer-metaxalone prodrug and synthesis method thereof |
| 11/02/2011 | CN102228695A Method for preparing basic fibroblast growth factor sustained-release carrier |
| 11/02/2011 | CN102228694A Active PDGFR (Platelet-derived Growth Factor Receptor)-beta targeting drug delivery system and preparation method thereof |
| 11/02/2011 | CN102228693A Preparation method for drug release hydrogel membrane with electron beam |
| 11/02/2011 | CN102228687A Freeze-dried live attenuated hepatitis A vaccine not containing gelatin or human albumin protective agent and preparation method for freeze-dried live attenuated hepatitis A vaccine |
| 11/02/2011 | CN102228680A Thymosin phospholipids/bile salt compound micelle and preparation method and preparation thereof |
| 11/02/2011 | CN102228677A 21 (R) argatroban intravenous injection containing acid as solubiliser |
| 11/02/2011 | CN102228676A Heparolysate injection pharmaceutical composition |
| 11/02/2011 | CN102228597A Medicament for treating oral ulcer and preparation method |
| 11/02/2011 | CN102228511A Soft capsule for treating cardiovascular diseases and preparation method thereof |
| 11/02/2011 | CN102228506A Composition of malaytea scurfpea extract as well as preparation method and use thereof |
| 11/02/2011 | CN102228501A Chinese medicinal composition for resisting anoxia and fatigue and preparation method thereof |
| 11/02/2011 | CN102228491A Orally rapid disintegrating tablet of isatidis root extract and preparation method thereof |
| 11/02/2011 | CN102228483A Freeze-dried preparation of xanthone anti-tumour medicine and preparation method thereof |
| 11/02/2011 | CN102228478A Medicinal composition for treating blood stasis and qi stagnation syndrome of primary liver cancer and preparation method thereof |
| 11/02/2011 | CN102228474A Compound dry suspension used for treating children's cold and its preparation method |
| 11/02/2011 | CN102228470A Preparation method and purpose of copper-loaded chitosan antiseptic |
| 11/02/2011 | CN102228469A Nano-selenium particles and preparation method thereof |
| 11/02/2011 | CN102228467A Application of hydrogen physiological saline in preparation for medicine treating acute neurological damage diseases |
| 11/02/2011 | CN102228459A Sodium rabeprazole composition used for injection |
| 11/02/2011 | CN102228448A Cefuroxime axetil tablet and direct all-powder compression method thereof |
| 11/02/2011 | CN102228446A Alprostadil lipid nanosphere freeze-drying injection and preparation method thereof |
| 11/02/2011 | CN102228443A Clevidipine butyrate microspheres and preparation method thereof |
| 11/02/2011 | CN102228442A Star-like macromolecule nanometer microsphere and preparation method and application thereof |
| 11/02/2011 | CN102228441A Dexibuprofen sustained-release pellet and preparation method thereof |
| 11/02/2011 | CN102228440A Method for preparing hydrophilic drug microsphere through spray drying process |
| 11/02/2011 | CN102228439A Gel microsphere capable of being injected with rifamycinoid antibiotics and preparation method thereof |
| 11/02/2011 | CN102228438A Decoquinate gel microsphere and its preparation method |
| 11/02/2011 | CN102228437A Co-immobilized TNF-a/IFN-g/DOX/FA/Fe3O4-OA magnetic targeted nanoparticle as well as preparation method and application thereof |
| 11/02/2011 | CN102228436A Slow-release liquid crystal nanoparticle containing vinpocetine prepared by supercritical fluid method |
| 11/02/2011 | CN102228435A Water-soluble vitamin liposome pharmaceutical composition formula and preparation method and application thereof |
| 11/02/2011 | CN102228434A Clevidipine butyrate emulsion, preparation method thereof and purpose thereof |
| 11/02/2011 | CN102228433A Supersaturated self-microemulsion as well as preparation method and application thereof |
| 11/02/2011 | CN102228431A Self-emulsified medicinal composition for taxane compounds |
| 11/02/2011 | CN102228430A Nano-suspension for silybin-phospholipid complex and preparation method thereof |
| 11/02/2011 | CN102228429A Lomefloxacin aspartate medicine composition for injection |
| 11/02/2011 | CN102228428A Large volume injection composition containing vinpocetine and preparation method thereof |
| 11/02/2011 | CN102228426A 21(R) argatroban intravenous injection with alcohol as solubilizer |
| 11/02/2011 | CN102228425A Tumor-targeted magnetic hydrogel nanoscale medicine delivery system and construction method and application thereof |
| 11/02/2011 | CN102228424A Drug sustained-release system for treating tumours and preparation method thereof |
| 11/02/2011 | CN102228423A Tolvaptan oral solid medicinal composition and preparation method thereof |
| 11/02/2011 | CN101891890B Method for preparing biodegradable poly (alpha, beta-L-aspartic acid) |
| 11/02/2011 | CN101890045B External medicament for treating infantile eczema |
| 11/02/2011 | CN101732492B Adinandra nitida leaf flavone oral tablet and preparation method |
| 11/02/2011 | CN101695489B Aztreonam composition, powder injection and preparation method thereof |
| 11/02/2011 | CN101693029B Oral preparation having improved bioavailability |
| 11/02/2011 | CN101665574B Degradable polyethyleneimine (PCFC-PEI) polymer preparation method and application in drug delivery system |
| 11/02/2011 | CN101647844B Vinegar milk essence micro effervescent granules and preparation method thereof |
| 11/02/2011 | CN101574397B WuRenChun self-emulsifying soft capsule preparation and preparation method |
| 11/02/2011 | CN101531718B Anti-VEGFR-2 antibody chimeric Fab antibody fragment, preparation method and application thereof |
| 11/02/2011 | CN101385860B Camptothecine and non-linear polyethyleneglycol prodrug of derivative thereof |
| 11/02/2011 | CN101190208B Medicinal preparations containing duloxetine hydrochloride and preparation method thereof |
| 11/02/2011 | CN101104078B Polypeptide and protein medicine polyethylene coupling compound |
| 11/02/2011 | CN101073537B Fine emulsion of oil in water |
| 11/01/2011 | US8048989 Biodegradable biopolymers, method for their preparation and functional materials constituted by these biopolymers |
| 11/01/2011 | US8048983 HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| 11/01/2011 | US8048930 Activated peroxide solutions and a process for the preparation thereof |
| 11/01/2011 | US8048919 Use of ethyl lactate as an excipient for pharmaceutical compositions |
| 11/01/2011 | US8048913 Compositions and products containing S-equol, and methods for their making |
| 11/01/2011 | US8048865 Method and pharmaceutical to treat spinal discs |